Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CPU 86017. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1156474C details novel chiral isoquinoline synthesis offering improved solubility and bioavailability for cardiovascular drug manufacturing.
Patent CN1403456A details a novel resolution and quaternization process for chiral tetrahydroberberine, offering cost reduction in cardiovascular drug manufacturing and enhanced supply chain reliability.